BlackRock, Inc. (NYSE:BLK) Shares Sold by Physician Wealth Advisors Inc.

Physician Wealth Advisors Inc. lowered its position in BlackRock, Inc. (NYSE:BLK) by 6.3% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 329 shares of the asset manager’s stock after selling 22 shares during the period. Physician Wealth Advisors Inc.’s holdings in BlackRock were worth $331,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the company. Redmont Wealth Advisors LLC purchased a new position in BlackRock during the first quarter worth approximately $27,000. Fairscale Capital LLC acquired a new stake in BlackRock in the 2nd quarter valued at $31,000. Chilton Capital Management LLC purchased a new stake in BlackRock in the 1st quarter worth $38,000. Olistico Wealth LLC acquired a new position in BlackRock during the second quarter worth $53,000. Finally, ORG Partners LLC lifted its holdings in BlackRock by 257.9% during the second quarter. ORG Partners LLC now owns 68 shares of the asset manager’s stock valued at $54,000 after purchasing an additional 49 shares in the last quarter. 80.69% of the stock is owned by hedge funds and other institutional investors.

BlackRock Stock Up 0.9 %

BLK stock opened at $1,015.70 on Thursday. BlackRock, Inc. has a one year low of $596.18 and a one year high of $1,019.22. The firm has a market cap of $150.93 billion, a PE ratio of 25.81, a PEG ratio of 1.94 and a beta of 1.30. The firm’s 50 day moving average price is $909.48 and its 200-day moving average price is $834.95. The company has a debt-to-equity ratio of 0.37, a quick ratio of 5.06 and a current ratio of 5.06.

BlackRock (NYSE:BLK) last posted its earnings results on Friday, October 11th. The asset manager reported $11.46 EPS for the quarter, beating analysts’ consensus estimates of $10.42 by $1.04. The company had revenue of $5.20 billion for the quarter, compared to the consensus estimate of $5.03 billion. BlackRock had a return on equity of 15.44% and a net margin of 32.36%. The company’s revenue for the quarter was up 14.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $10.91 earnings per share. On average, equities research analysts anticipate that BlackRock, Inc. will post 41.73 EPS for the current year.

BlackRock Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, September 23rd. Shareholders of record on Monday, September 9th were given a dividend of $5.10 per share. This represents a $20.40 dividend on an annualized basis and a dividend yield of 2.01%. The ex-dividend date of this dividend was Monday, September 9th. BlackRock’s dividend payout ratio is presently 51.84%.

Insider Transactions at BlackRock

In related news, CEO Laurence Fink sold 29,450 shares of BlackRock stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $843.25, for a total value of $24,833,712.50. Following the completion of the sale, the chief executive officer now owns 353,718 shares in the company, valued at approximately $298,272,703.50. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, CEO Laurence Fink sold 29,450 shares of the stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $843.25, for a total transaction of $24,833,712.50. Following the transaction, the chief executive officer now owns 353,718 shares of the company’s stock, valued at approximately $298,272,703.50. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Pamela Daley sold 1,531 shares of BlackRock stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $842.08, for a total value of $1,289,224.48. Following the completion of the transaction, the director now directly owns 5,732 shares of the company’s stock, valued at approximately $4,826,802.56. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 66,042 shares of company stock worth $56,857,777. 0.90% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research analysts recently weighed in on BLK shares. Deutsche Bank Aktiengesellschaft upped their price target on shares of BlackRock from $912.00 to $937.00 and gave the stock a “buy” rating in a research report on Thursday, August 15th. Barclays raised their target price on BlackRock from $1,010.00 to $1,120.00 and gave the company an “overweight” rating in a research report on Monday. StockNews.com initiated coverage on BlackRock in a research report on Saturday, October 12th. They set a “hold” rating for the company. Argus raised their price objective on BlackRock from $880.00 to $910.00 and gave the company a “buy” rating in a report on Tuesday, July 16th. Finally, Evercore ISI upped their target price on shares of BlackRock from $995.00 to $1,040.00 and gave the stock an “outperform” rating in a report on Monday. Three equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $991.46.

BlackRock Profile

BlackRock, Inc is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.